SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat ($SOLYCAT) is gaining traction, with community members highlighting its availability on Phantom Wallet and relative stability amidst market fluctuations. The crypto is being touted as a potential "moon" candidate, with buyers sharing enthusiasm. Conversations are centered on its performance within the Solana ecosystem.

Moo Deng

MOODENG is trending as traders discuss recent price volatility and potential for a breakout. Community members are debating entry points, with some pointing to technical analysis patterns, while others express skepticism, citing its meme coin status and past performance. The coin's listing on Robinhood and upcoming birthday are also being mentioned as potential catalysts.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

GBTC is trending as Bitcoin flirts with all-time highs, driving discussion about potential breakouts and future price targets. Community members are closely watching technical indicators and whale activity, anticipating a continued uptrend. Broader market factors, like potential shifts from gold to Bitcoin and the impact of government policies, are also being considered.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending following FDA approval of their leukemia drug, Revuforj, though a boxed warning regarding potentially fatal side effects tempers initial enthusiasm. The community is debating the impact of the safety label, comparing it to competitor Kura Oncology's profile, and weighing whether the market is overreacting given the drug's efficacy and the unmet need it addresses. Some believe the dip is a buying opportunity, while others worry about potential risks and side effects.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

ProShares Short Dow30 ($DOG) is trending as community members discuss its potential as a Bitcoin-native meme coin, emphasizing its fair launch and strong community. Some see it as a compelling opportunity within the crypto space, drawing comparisons to other popular meme coins and highlighting its unique position on the Bitcoin network. Community members are actively sharing insights and expressing bullish sentiment, with some anticipating significant growth and exchange listings.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending amid discussions about a potential recall of specific lots and the impact on revenue, with community members analyzing the company's response and comparing it to similar situations with competitors. Some traders are interpreting recent stock sales by the CEO, alongside an FDA safety notice, while others suggest potential manufacturing issues. Despite concerns, many community members express confidence in the company's long-term growth and potential for a buyback.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending due to growing community engagement and real-world applications, with discussions focusing on its expanding ecosystem and the potential for significant growth. Community members highlight KENDU's unique approach as a permissionless brand, its active IRL presence, and the increasing number of holders. The recent release of a new website is also generating excitement, with many expressing confidence in KENDU's long-term potential.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending as the stock price continues to drop post FDA approval, leading to discussions around management, dilution, and future prospects. The community is debating whether the current price represents a buying opportunity or reflects deeper issues with the company's leadership and commercialization strategy. Some traders are noting potential short squeeze setups due to high short interest.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya is trending as investors discuss upcoming earnings and the company's potential for growth in the consumer credit sector, with some highlighting the AI-driven model as a key differentiator against competitors. Community members are debating the impact of recent bankruptcies of subprime lenders and analyzing insider trading activity, while also assessing the stock's valuation relative to peers like Upstart. Discussions also include speculation around potential deregulation and its impact.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

RIGL is trending due to increasing optimism surrounding its upcoming earnings and potential undervaluation, as highlighted by a low P/E ratio. The community is actively discussing the high short interest and potential for a short squeeze, with some speculating about a possible buyout. Positive analyst ratings and strong sales growth for key products like Tavalisse are also fueling investor interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Asia fuels one of the steepest gold rallies since 1970s amid 2025 price surge

New Delhi, Oct 16 : The surge in gold prices in 2025 ranks among the steepest since the 1970s, rivalling the bull runs of 197980, 201011, and 2020. However, unlike earlier cycles driven by Western crises, this rally is Asia-led, underpinned by reserve diversification and official-sector demand, data from a report showed on Thursday. Golds dazzling rally this year has captivated global markets a rare and spectacular ascent that has seen prices surge over 50 per cent year-to-date, breaching $4,000 on COMEX and touching Rs 1,20,000 domestically. The precious metal has clocked over 35 new record highs this year, as investors embrace tangible assets amid global uncertainty. Silver too has mirrored golds brilliance, soaring over 60 per cent YTD across exchanges, Motilal Oswal Financial Services said in its report. What began as a cautious start to the year has turned into a full-fledged super cycle, driven by capital rotation from bonds and riskier assets into safe havens. The rally in precious metals has been underpinned by a steady dollar index below 100 and rupee appreciation, both of which have supported domestic prices. "Markets are now pricing in a 70 per cent probability of U.S.

Silver shortage grips Zaveri Bazar

Even though the price of silver has fallen by Rs 2,000 per kg to 1.74 lakh in a day, jewellers from Zaveri Bazar has stopped accepting fresh orders for silver ornaments and bullion due to a severe shortage of physical silver, according to Rajesh Rokde, chairman of All India Gem & Jewellery Domestic Council (GJC).Rokde said that the premium on physical silver has surged significantly, reaching up to Rs 30,000 per kilogram, driven by strong demand and limited supply. This shortage is attributed to increased industrial and investment demand, both locally and globally.The GJC chairman said that strong demand from countries like Australia, Turkey, and China is exacerbating the shortage. "Some experts predict a temporary correction in prices around November, but overall appreciation is expected in the long term," he said.A report released by Motilal Oswal Financial Services Ltd. (MOFSL) on long-term outlook on silver till 2030 said that silver prices have surged past $51.30 per ounce in October 2025, registering over 70% year-to-date gains and reaching a 14-year high.

Shares of Motilal Oswal Financial Services rose as much a 4% to ₹1,010, after ICRA upgraded the company’s long-term rating to [ICRA]AA+ (Stable) from “[ICRA]AA (Positive) and reaffirmed the short-term rating at [ICRA]A1+.ICRA highlighted Motilal Oswal Financial Services’ ability to leverage sector growth, strengthen its franchise across businesses, and maintain resilient financial performance despite changing market and regulatory conditions.The rating was based on a consolidated view of the Motilal Oswal Group, including its subsidiaries, Motilal Oswal Home Finance, Motilal Oswal Finvest, Motilal Oswal Wealth, and Motilal Oswal Broking and Distribution.“The upgrade to [ICRA]AA+ reflects the strength of our balance sheet and net worth, diversified business model, and disciplined financial management. The upgrade is expected to enhance MOFSL’s borrowing capacity, lower its cost of funds, and boost investors and lenders confidence, thereby improving access to institutional capital and supporting the company’s growth plans across business verticals,” said Shalibhadra Shah, Chief Financial Officer, Motilal Oswal.“The rating upgrade signifies our company’s increased creditworthiness and reduced risk profile, making us a more attractive and reliable, well-diversified capital market player. We believe this upgrade will open new opportunities for growth across our businesses,” Shah added.What Is The Retail Mood?Retail sentiment on Stocktwits remained ‘bullish’ on Monday. It was ‘bearish’ last week. It was also among the top 10 trending stocks on the platform.<figure class="image"><img style="aspect-ratio:927/97;" src="https://news.stocktwits-cdn.com/Motilal_Oswal_png_38e90f1286.webp" alt="Motilal Oswal.png" width="927" height="97"><figcaption>Motilal Oswal's Sentiment Meter and Message Volumes at 02:45 p.m. IST on October 13 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/MOTILALOFS.NSE">Motilal Oswal's shares</a> gained in six of the last eight sessions and hit their highest level since December 2024, on Monday.Year-to-date, Motilal Oswal shares have climbed 5.7%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Motilal Oswal Stock Near 10-Month High On ICRA Ratings Upgrade

ICRA highlighted Motilal Oswal Financial Services’ ability to leverage sector growth, strengthen its franchise across businesses, among key reasons for upgrade

Equity

Groww set to launch Rs 7,000 crore IPO in November

Mumbai: Brokerage Groww is looking to launch its ₹7,000-crore Initial Public Offering (IPO) in the first week of November, said banking sources in the know. The Bengaluru-based firm, backed by Microsoft Chief Executive Officer Satya Nadella, is expected to announce the price band for its issue by the end of October, they said.Billionbrains Garage Ventures, Groww's parent, is targeting a valuation of up to $8 billion (approximately ₹70,400 crore) in its IPO. Kotak Mahindra Capital, JP Morgan India, Citigroup Global Markets India, Axis Capital, and Motilal Oswal Investment Advisors are the book-running lead managers to the IPO.Emails sent to the company and the bankers remained unanswered.Of the ₹7,000 crore IPO size, the fresh issue component will be ₹1,060 crore, while the rest will be an offer for sale (OFS) of up to 57.42 crore equity shares by existing investors, including Nadella.October saw some of the biggest IPOs of the year, including Tata Capital's ₹15,500-crore issue, the largest so far, followed by LG Electronics' ₹11,600-crore IPO.

Markets poised for growth; reforms, festive demand driving optimism: Motilal Oswal

Motilal Oswal, MD & CEO of Motilal Oswal Financial Services Ltd (MOFSL), expressed confidence in India's market outlook, citing strong reform momentum and encouraging festive demand.

Indian benchmarks to open flat as US trade optimism balances visa worries

India’s equity benchmarks are set to open little changed on Tuesday, as optimism over progress in trade talks with the United States helped balance concerns about steep H-1B visa fees. Gift Nifty futures were trading at 25,256.5 points as of 07:55 a.m. IST, indicating that the benchmark Nifty 50 will open near Monday’s close of 25,202.35. On Monday, both the Nifty 50 and the BSE Sensex fell, dragged by major information technology stocks that together lost about $10 billion in market value after Washington announced a $100,000 fee on new H-1B applications. Sentiment improved, however, after U.S. Secretary of State Marco Rubio underscored the importance of ties with India during talks with External Affairs Minister Subrahmanyam Jaishankar on the sidelines of the UN General Assembly in New York. “Indian equities are likely to consolidate after the recent run-up and Monday’s dip, with focus on Commerce Minister Piyush Goyal’s US visit for trade negotiations,” said Siddhartha Khemka, head of research, wealth management at Motilal Oswal Financial Services.

Motilal Oswal Financial Services Ltd. is a non-banking financial company, which engages in providing a range of financial products and services such as private wealth, retail broking and distribution, institutional broking, asset management, investment banking, private equity, commodity broking, currency broking, and home finance. It operates through the following segments: Capital Market, Asset and Wealth Management, Home Finance, and Treasury Investments. The Capital Market segment includes broking services to clients, research and advisory services, financial product distribution, depository services, investment banking, and margin trading funding. The Asset and Wealth Management segment offers fee-based services for management of assets. The Home Finance segment represents interest and other related income from affordable housing finance business. The Treasury Investments segment refers to investment and financing activities. The company was founded on May 18, 2005, and is headquartered in Mumbai, India.

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	N/A
50-Day Moving Average	937.52
Beta	-0.09
Avg. Volume	775,102.18
PE Ratio	22.30

52-Week High	1,045.00
52-Week Low	513.00
Market Capitalization	622.25B
EPS (Annual)	41.83
Price to Book	5.61
Revenue Per Employee	5.68M
Enterprise Value/EBITDA	N/A

MOTILALOFS.NSE
Motilal Oswal Financial Services Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest MOTILALOFS.NSE News

MOTILALOFS.NSEMotilal Oswal Financial Services Ltd.